Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Is UVC the Future of Infection Prevention Technology?

The risk of cross-contamination and mass infections in healthcare settings has always been an issue, but in the midst of a raging pandemic, that problem has been exacerbated even further. However, with many hospitals, nursing homes and other healthcare facilities already stretched thin, an affordable solution that requires minimal time and effort to use is…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The risk of cross-contamination and mass infections in healthcare settings has always been an issue, but in the midst of a raging pandemic, that problem has been exacerbated even further.

However, with many hospitals, nursing homes and other healthcare facilities already stretched thin, an affordable solution that requires minimal time and effort to use is needed. Can UVC technology fill this gap?

Daniel Litwin met with Christopher Allen, CEO of iCleanse, to get his thoughts on the matter. iCleanse is a chemical-free disinfection company that uses UVC light to disinfect surfaces and spaces in 60 seconds or less, with Allen bringing over a decade of experience in IoT technology to the organization.

The COVID-19 pandemic has quickly brought UVC technology to the forefront of infection prevention strategies in the healthcare setting, establishing it as the standard that all other technologies must follow.

One additional, unexpected benefit that UVC products offer healthcare companies is increased employee satisfaction.

“It’s so hard to find new folks to come on board, and there’s a shortage in general,” Allen said. “So, giving them the opportunity to disinfect their phone and tablet, whatever’s in their pocket, before they come to the facility, but also when they go home to their families – that gives them a lot of peace of mind that they are not bringing COVID home with them and not exposing their children or their loved ones to this pandemic.”

Visit surfacide.com for more information on the services and solutions we offer. Make sure to subscribe to A Move in the Light Direction, for the latest insights on how to create a safer environment wherever you go.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512